Michael Cejnar - Comment

Document ID: FDA-2009-N-0458-0012
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 19 2013, at 12:00 AM Eastern Standard Time
Date Posted: April 4 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: February 19 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: April 22 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-83rz-jxlj
View Document:  View as format xml

View Comment

As a medical specialist cardiologist, the definition of paediatric as 0-21 years may have some legal basis, but medically seems bizarre and nonsensical. To me it seems like it will defeat any intent of this rule. The legal precedent for the 21 year definition relating to Paediatric exemptions was extremely generous with the age up to 21 years - as it did no harm and probably usefully covered some congenital disorders (like cardiac ones) which required follow up surgery and treatment into the 20's. However, a 21 year old can get almost all diseases that an 'adult ' gets, so your rule may be expected to cause the notification from almost all medical devices on the market, except for those with intended use restricted to geriatric patients like perhaps adult incontinence pads or Zimmer frames. If there is some valid medical reason behind this age limit, it would be most useful to feature that reason prominently in the rule.

Related Comments

   
Total: 4
Michael Cejnar - Comment
Public Submission    Posted: 04/04/2013     ID: FDA-2009-N-0458-0012

Apr 22,2013 11:59 PM ET
Advanced Medical Technology Association (AdvaMed) - Comment
Public Submission    Posted: 04/26/2013     ID: FDA-2009-N-0458-0013

Apr 22,2013 11:59 PM ET
American Academy of Pediatrics, Elizabeth Glaser Pediatric AIDS Foundation - Comment
Public Submission    Posted: 04/26/2013     ID: FDA-2009-N-0458-0015

Apr 22,2013 11:59 PM ET
Cook Group, Inc. - Comment
Public Submission    Posted: 04/26/2013     ID: FDA-2009-N-0458-0014

Apr 22,2013 11:59 PM ET